Instil Bio (TIL) Net Cash Flow (2020 - 2026)
Instil Bio (TIL) posted quarterly Net Cash Flow of -$1.7 million for Q1 2026, down 129.28% year-over-year from $5.6 million in Q1 2025, and down 322.91% quarter-over-quarter from $742000.0 in Q4 2025.
Instil Bio (TIL) Net Cash Flow (2020 - 2026) Analysis & Trends
Instil Bio's Net Cash Flow history runs 7 years deep, the most recent figure standing at -$1.7 million for Q1 2026.
- In Q1 2026, Net Cash Flow fell 129.28% year-over-year to -$1.7 million; the TTM figure through Mar 2026 stood at -$11.2 million (down 202.98% YoY), while the FY2025 annual figure was -$3.9 million, down 11769.7% from the prior year.
- Net Cash Flow for Q1 2026 stood at -$1.7 million, down from $742000.0 in the prior quarter.
- The five-year high for Net Cash Flow was $23.2 million in Q1 2022, with the low at -$18.1 million in Q2 2022.
- The 5-year median for Net Cash Flow is -$782000.0 (2022), against an average of -$1.9 million.
- The sharpest annual moves came in 2023 and 2024: Net Cash Flow slumped 1523.27% in 2023, then soared 609.49% in 2024.
- Instil Bio's Net Cash Flow stood at $2.0 million in 2022, then sank by 71.94% to $569000.0 in 2023, then jumped by 609.49% to $4.0 million in 2024, then tumbled by 81.62% to $742000.0 in 2025, then sank by 322.91% to -$1.7 million in 2026.
- Business Quant data shows TIL's Net Cash Flow at -$1.7 million in Q1 2026, $742000.0 in Q4 2025, and -$1.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.93 Bn | 131.08 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 86.11 Bn | 78.11 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 65.43 Bn | 60.25 Bn | 1.37 Bn | - |
| 4 | Moderna | 56.09 Bn | 50.96 Bn | 52.00 Mn | -183.00 Mn |
| 5 | BeOne Medicines | 42.13 Bn | 37.03 Bn | 1.53 Bn | 407.41 Mn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn | -496,000.00 |
| 7 | BioNTech SE | 27.68 Bn | 9.29 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.49 Bn | 26.32 Bn | 358.27 Mn | -37.14 Mn |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | 225.59 Mn |
| 10 | Instil Bio | 53.44 Mn | 53.44 Mn | - | 649,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 649,000.00 |
| Jun 30, 2026 | 649,000.00 |
| Mar 31, 2026 | -1.65 Mn |
| Mar 31, 2026 | -1.65 Mn |
| Dec 31, 2025 | 742,000.00 |
| Dec 31, 2025 | 742,000.00 |
| Sep 30, 2025 | -1.73 Mn |
| Sep 30, 2025 | -1.73 Mn |
| Jun 30, 2025 | -8.51 Mn |
| Jun 30, 2025 | -8.51 Mn |
| Mar 31, 2025 | 5.65 Mn |
| Mar 31, 2025 | 5.65 Mn |
| Dec 31, 2024 | 4.04 Mn |
| Dec 31, 2024 | 4.04 Mn |
| Sep 30, 2024 | -160,000.00 |
| Sep 30, 2024 | -160,000.00 |
| Jun 30, 2024 | 1.31 Mn |
| Jun 30, 2024 | 1.31 Mn |
| Mar 31, 2024 | -5.15 Mn |
| Mar 31, 2024 | -5.15 Mn |